文献速递泌尿生殖介入MR

术中扩散加权成像预测前列腺癌MRI引导聚焦超声消融范围的初步研究

Intraprocedural Diffusion-weighted Imaging for Predicting Ablation Zone during MRI-guided Focused Ultrasound of Prostate Cancer.
PubMed 文献 · Radiol Imaging Cancer · 2024-01-01

这项前瞻性试验的二次分析纳入17例接受MRgFUS治疗的前列腺癌患者,于治疗后立即行DWI,并以T1加权无灌注区(NPV)为参考标准比较DWI与热剂量学预测消融边界的准确性。DWI勾画的轮廓与NPV的Dice相似系数为0.84±0.05、平均Hausdorff距离为0.27 mm±0.13,均优于热剂量学轮廓(DSC为0.64±0.12、mHD为1.53 mm±1.20,P < .001)。

要点

  • DWI在消融区边缘显示高信号环,可直接勾画消融范围。
  • DWI轮廓与增强后NPV轮廓的DSC为0.84±0.05,优于热剂量学的0.64±0.12。
  • 热剂量学轮廓低估了消融范围,DWI与参考标准吻合更好。

核心结论

  • DWI可直接显示消融区,是有前景的无对比剂方法,对治疗相关整体运动稳健,与T1加权NPV参考标准的相关性优于热剂量学。

研究设计与样本

  • 前瞻性试验(NCT01657942)的二次分析,纳入17例(平均年龄64岁±6,均为男性)接受MRgFUS治疗的前列腺癌患者,治疗后立即行DWI;两名盲法放射科医师勾画热剂量学和DWI消融轮廓,以治疗后增强T1加权无灌注区(NPV)轮廓为参考标准。

关键影像表现/征象

  • DWI在消融区边缘显示高信号环。
  • 热剂量学轮廓较T1加权NPV参考标准低估消融范围。
  • DWI勾画轮廓与增强后NPV轮廓的平均DSC为0.84±0.05,mHD为0.27 mm±0.13。
  • 热剂量学轮廓与增强后NPV轮廓的平均DSC为0.64±0.12,mHD为1.53 mm±1.20。

诊断标准与关键数值

  • DWI轮廓与增强后NPV轮廓的平均DSC为0.84±0.05,mHD为0.27 mm±0.13。
  • 热剂量学轮廓与增强后NPV轮廓的平均DSC为0.64±0.12,mHD为1.53 mm±1.20。
  • DWI与热剂量学轮廓预测消融区的差异P < .001。

临床应用与阅片要点

  • DWI可在治疗后立即无对比剂显示消融区,对治疗相关整体运动稳健。
  • 热剂量学轮廓可能低估消融范围,阅片时需结合DWI评估边界。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To compare diffusion-weighted imaging (DWI) with thermal dosimetry as a noncontrast method to predict ablation margins in individuals with prostate cancer treated with MRI-guided focused ultrasound (MRgFUS) ablation. Materials and Methods This secondary analysis of a prospective trial (ClinicalTrials.gov no. NCT01657942) included 17 participants (mean age, 64 years ± 6 [SD]; all male) who were treated for prostate cancer using MRgFUS in whom DWI was performed immediately after treatment. Ablation contours from computed thermal dosimetry and DWI as drawn by two blinded radiologists were compared against the reference standard of ablation assessment, posttreatment contrast-enhanced nonperfused volume (NPV) contours. The ability of each method to predict the ablation zone was analyzed quantitively using Dice similarity coefficients (DSCs) and mean Hausdorff distances (mHDs). Results DWI revealed a hyperintense rim at the margin of the ablation zone. While DWI accurately helped predict treatment margins, thermal dose contours underestimated the extent of the ablation zone compared with the T1-weighted NPV imaging reference standard. Quantitatively, contour assessment between methods showed that DWI-drawn contours matched postcontrast NPV contours (mean DSC = 0.84 ± 0.05 for DWI, mHD = 0.27 mm ± 0.13) better than the thermal dose contours did (mean DSC = 0.64 ± 0.12, mHD = 1.53 mm ± 1.20) (P < .001). Conclusion This study demonstrates that DWI, which can visualize the ablation zone directly, is a promising noncontrast method that is robust to treatment-related bulk motion compared with thermal dosimetry and correlates better than thermal dosimetry with the reference standard T1-weighted NPV. Keywords: Interventional-Body, Ultrasound-High-Intensity Focused (HIFU), Genital/Reproductive, Prostate, Oncology, Imaging Sequences, MRI-guided Focused Ultrasound, MR Thermometry, Diffusionweighted Imaging, Prostate Cancer ClinicalTrials.gov Identifier no. NCT01657942 Supplemental material is available for this article. © RSNA, 2024.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Bitton RR, Shao W, Chodakeiwitz Y, et al. Intraprocedural Diffusion-weighted Imaging for Predicting Ablation Zone during MRI-guided Focused Ultrasound of Prostate Cancer. Radiol Imaging Cancer. 2024. PMID: 39212524. doi:10.1148/rycan.240009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。